SENSEI BIOTHERAPEUTICS INC (SNSE)

US81728A1088 - Common Stock

0.5264  +0.02 (+4.24%)

After market: 0.5359 +0.01 (+1.8%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
32.48M37.06M50.19M37.49M18.72M
Research and Development
18.63M18.30M30.38M21.66M11.19M
Selling, General, and Administrative Expenses
13.85M18.77M19.81M15.82M7.53M
Operating Income
-32.48M-37.06M-50.19M-37.49M-18.72M
Interest Income/Expense
2.75M3.48M1.56M130.00K-690.00K
Other Income/Expense
-69.00K-215.00KN/A690.00K0.00
Non Recurring Items
N/AN/A0.00570.00K-690.00K
Income Before Taxes
-29.80M-34.10M-48.59M-36.79M-20.10M
Net Income
-29.80M-34.10M-48.59M-36.79M-20.20M
EBITDA
-31.16M-35.71M-48.84M-36.80M-18.51M
 
Per Share Data
EPS Diluted Total Ops
-1.19-1.22-1.58-1.33-0.68
Non GAAP EPS
-1.19-1.22-1.58-1.36N/A
 
Statistics

All data in USD

Charts